Home / Health / GLP-1s Safe in Early Pregnancy? New Data Offers Reassurance
GLP-1s Safe in Early Pregnancy? New Data Offers Reassurance
9 Jun
Summary
- Early GLP-1 drug use in pregnancy not cause for alarm.
- Non-live birth risk shows no significant difference.
- Major birth defects risk not substantially increased.
A large data analysis indicates that using GLP-1 medications for diabetes or obesity early in the first trimester, prior to pregnancy recognition, is not a cause for concern. These drugs, including semaglutide and tirzepatide, are generally not recommended during pregnancy due to unknown fetal safety.
Researchers analyzed over 3,500 pregnancies, comparing outcomes for those continuing GLP-1 use into the first trimester versus those who stopped. The study found no statistically significant increase in the risk of non-live birth. Similarly, risks for low or high birth weight and major congenital malformations were not substantially elevated.
While current medical guidelines advise stopping GLP-1s before conception, this study offers reassurance regarding unintentional early exposure. Experts emphasize that pregnant women and those planning pregnancy should still follow medical advice regarding GLP-1 use.
